XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

NCT02350686 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

Samsung Medical Center